Research and Development

The Research and Development team at Acerta Pharma B.V. focuses on leveraging covalent binding technology to develop novel, highly selective therapies for cancer. This team of highly skilled scientists conducts advanced biological, bioinformatics, and translational research to identify and optimize breakthrough therapeutic compounds, aiming to improve patient outcomes in oncology.